DRD3 antibody (AA 213-329)
Quick Overview for DRD3 antibody (AA 213-329) (ABIN7149474)
Target
See all DRD3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 213-329
-
Cross-Reactivity
- Human
-
Purification
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human D(3) dopamine receptor protein (213-329AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- DRD3 (Dopamine Receptor D3 (DRD3))
-
Alternative Name
- DRD3
-
Background
-
Background: Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation.
Aliases: 3dopamine receptor antibody, D antibody, D(3) dopamine receptor antibody, Dopamine D3 receptor antibody, Dopamine receptor D3 antibody, DRD3 antibody, DRD3_HUMAN antibody, ETM1 antibody, FET1 antibody
-
UniProt
- P35462
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Proton Transport, Negative Regulation of Transporter Activity
Target
-